SPORFIX

This brand name is authorized in Nigeria.

Active ingredients

The drug SPORFIX contains one active pharmaceutical ingredient (API):

1	Cefixime UNII 97I1C92E55 - CEFIXIME
	Cefixime is an oral third generation cephalosporin which has marked in vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms.
	Read more about Cefixime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-0037	Powder for suspension	Sporfix Powder for Oral Suspension (check strength format) PWD_F_SOL 124.23mg 1 x 100 mL (in a bottle)	Powder for Suspension White colored free flowing granulated powder having characteristic odor 73 CMS-PP-322554 SPORFIX POWDER FOR ORAL SUSPENSION CEFIXIME TRIHYDRATE • Cefixime Trihydrate USP (Active Ingredient) 124.23mg. • Sugar BP (Sweetening Agent) 1058.17mg. • Xanthan Gum BP (Suspending Agent) 10mg. • Sodium Benzoate BP (Preservatives) 10mg. • Colloidal silicon Dioxide BP (Absorbent) 12.50mg. • Pineapple dry flavour HIS (Flavouring Agent) 25mg. • Sucralose BP (Sweetening Agent) 10mg. • Quinoline yellow HIS (Colouring Agent) 0.1mg. B4-0037 Drugs Imported Products 1x100ml Prescription Only Medicine (POM) 4/11/2023 NOMEDI PHARMACEUTICALS LIMITED, 387 Agege motor road Mushin 17412135 victoria.ezeala@nomedipharma-ng.com Health Care Formulations Pvt Ltd. , C/8, Sardar Estate, Ajwa Road, Vadodara 390019, India., India	21/12/2023
B4-0050	Capsule	Sporfix Capsules CAP 400 mg 1 x 10's (in AIu-AIu blister)	Capsule Hard gelatin capsule size ‘’0’’ blue cap/white body containing off white powder 74 CMS-PP-323793 SPORFIX CAPSULES CEFIXIME TRIHYDRATE Cefixime 400mg Microcrystalline Cellulose, Magnesium Stearate, Croscarmellose Sodium, Sodium Lauryl sulphate, Starch. B4-0050 Drugs Imported Products 110packs Prescription Only Medicine (POM) 4/6/2023 NOMEDI PHARMACEUTICALS LIMITED, 387 Agege motor road Mushin 17412135 victoria.ezeala@nomedipharma-ng.com Health Care Formulations Pvt Ltd. , C/8, Sardar Estate, Ajwa Road, Vadodara 390019, India., India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD08	Cefixime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-0037, B4-0050